Rights and permissions
About this article
Cite this article
Mupirocin unlikely to reduce cost of CAPD management. Pharmacoecon. Outcomes News 202, 10 (1999). https://doi.org/10.1007/BF03274888
Published:
Issue Date:
DOI: https://doi.org/10.1007/BF03274888